News blog
Alliance Pharma
- BY: Andrew Hore |
- POSTED: 02/03/2009 |
Healthcare investor MVM Life Science Partners has acquired 9.3% of Alliance Pharma.
The pharmaceuticals supplier hopes that MVM, which has $500m under management, will be able to help it raise money to finance acquisitions of products. MVM will appoint one director to the Alliance board.
In the middle of February, RAB Capital reduced its stake from 11% to 9.5%. This is the second time this year that RAB has taken advantage of a rising share price to offload shares.
Shares in Alliance improved by 0.375p to 5p each, which values the company at £8.1m.
The 2008 figures will be published on 18 March. A profit of at least £2.3m is predicted.
© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|